Cargando…

A novel donor-derived cell-free DNA assay for the detection of acute rejection in heart transplantation

BACKGROUND: Endomyocardial biopsy (EMB), the reference surveillance test for acute rejection (AR) in heart transplant (HTx) recipients, is invasive, costly, and shows significant interobserver variability. Recent studies indicate that donor-derived cell-free DNA (dd-cfDNA), obtained non-invasively f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Paul J., Olymbios, Michael, Siu, Alfonso, Pinzon, Omar Wever, Adler, Eric, Liang, Nathan, Swenerton, Ryan, Sternberg, Jonathan, Kaur, Navchetan, Ahmed, Ebad, Chen, Yen-An, Fehringer, Gordon, Demko, Zachary P., Billings, Paul R., Stehlik, Josef
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9670834/ https://www.ncbi.nlm.nih.gov/pubmed/35577713 http://dx.doi.org/10.1016/j.healun.2022.04.002

Ejemplares similares

Clinical Validation of a Plasma Donor-derived Cell-free DNA Assay to Detect Allograft Rejection and Injury in Lung Transplant
por: Rosenheck, Justin P., et al.
Publicado: (2022)

Combining Donor-derived Cell-free DNA Fraction and Quantity to Detect Kidney Transplant Rejection Using Molecular Diagnoses and Histology as Confirmation
por: Halloran, Philip F., et al.
Publicado: (2022)

Analytical Validation of a Single-nucleotide Polymorphism-based Donor-derived Cell-free DNA Assay for Detecting Rejection in Kidney Transplant Patients
por: Altuğ, Yücel, et al.
Publicado: (2019)

Donor-derived Cell-free DNA Shows High Sensitivity for the Diagnosis of Pancreas Graft Rejection in Simultaneous Pancreas-kidney Transplantation
por: Ventura-Aguiar, Pedro, et al.
Publicado: (2022)

Antibody-mediated Rejection Without Detectable Donor-specific Antibody Releases Donor-derived Cell-free DNA: Results From the Trifecta Study
por: Halloran, Philip F., et al.
Publicado: (2023)

Variation in Assessing Renal Allograft Rejection: A National Assessment of Nephrology Practice
por: Peabody, John, et al.
Publicado: (2019)

Why Cell-Free DNA Can Be a “Game Changer” for Lung Allograft Monitoring for Rejection and Infection
por: Rosenheck, J.P., et al.
Publicado: (2022)

Cell‐free DNA fetal fraction in twin gestations in single‐nucleotide polymorphism‐based noninvasive prenatal screening
por: Hedriana, Herman, et al.
Publicado: (2019)

Comparison of two donor-derived cell-free DNA tests and a blood gene-expression profile test in heart transplantation
por: Rodgers, Nicholas, et al.
Publicado: (2023)

Combining the use of a fetal fraction‐based risk algorithm and probability of an informative redraw in noninvasive prenatal testing for fetal aneuploidy
por: Benn, Peter, et al.
Publicado: (2019)

Association Between Total Cell Free DNA and SARS-CoV-2 In Kidney Transplant Patients: A Preliminary Study
por: Reusing, Jose Otto, et al.
Publicado: (2022)

Internship with Multidisciplinary Heart Failure Team as a Meaningful High School Student Experience
por: Stehlik, Bruno, et al.
Publicado: (2020)

Auto-Rejection of Renal Donor-Origin Metastatic Melanoma
por: Kriegshauser, J. Scott, et al.
Publicado: (2015)

Vascularized Composite Allograft Rejection Is Delayed by Intrajejunal Treatment with Donor Splenocytes without Concomitant Immunosuppressants
por: Wallace, Christopher Glenn, et al.
Publicado: (2012)

Quality Assurance of Non-Invasive Prenatal Screening (NIPS) for Fetal Aneuploidy Using Positive Predictive Values as Outcome Measures
por: DiNonno, Wendy, et al.
Publicado: (2019)

Combining donor-derived cell-free DNA and donor specific antibody testing as non-invasive biomarkers for rejection in kidney transplantation
por: Obrișcă, Bogdan, et al.
Publicado: (2022)

Endothelial failure and rejection in recipients of corneas from the same donor
por: Downward, Lewis, et al.
Publicado: (2022)

Selective Recruitment of Large Lower Lobe Atelectasis on Donor Back Table in Rejected Donor Lungs
por: Okamoto, Toshihiro, et al.
Publicado: (2019)

Impact of Circulating Tumor DNA–Based Detection of Molecular Residual Disease on the Conduct and Design of Clinical Trials for Solid Tumors
por: Kasi, Pashtoon M., et al.
Publicado: (2022)

Re: Clinical experience across the fetal‐fraction spectrum of a non‐invasive prenatal screening approach with low test‐failure rate
por: Jelsema, R., et al.
Publicado: (2020)

THE EFFECT OF SKIN HOMOGRAFT REJECTION ON RECIPIENT AND DONOR MIXED LEUKOCYTE CULTURES
por: Oppenheim, Joost J., et al.
Publicado: (1965)

Donor-Derived Ip-10 Initiates Development of Acute Allograft Rejection
por: Hancock, Wayne W., et al.
Publicado: (2001)

Approaching treatment for immunological rejection of living-donor liver transplantation in rats
por: Feng, Yanhu, et al.
Publicado: (2020)

Donor-Derived Cell-Free DNA and Active Rejection in Renal Allografts
por: Fernando, Edwin, et al.
Publicado: (2023)

Plan for blood banks to protect blood donors and healthcare workers during COVID-19 pandemic
por: Ali, Sheikh Muhammad Ebad, et al.
Publicado: (2020)

Systematic identification of ACE2 expression modulators reveals cardiomyopathy as a risk factor for mortality in COVID-19 patients
por: Kaur, Navchetan, et al.
Publicado: (2022)

Donor Rejection Before Living Donor Liver Transplantation: Causes and Cost Effective Analysis in an Egyptian Transplant Center.
por: El-Meteini, Mahmoud, et al.
Publicado: (2014)

Suppression of liver transplant rejection by anti-donor MHC antibodies via depletion of donor immunogenic dendritic cells
por: Ueta, Hisashi, et al.
Publicado: (2020)

Optimizing Detection of Kidney Transplant Injury by Assessment of Donor-Derived Cell-Free DNA via Massively Multiplex PCR
por: Sigdel, Tara K., et al.
Publicado: (2018)

Clinician‐reported chorionicity and zygosity assignment using single‐nucleotide polymorphism‐based cell‐free DNA: Lessons learned from 55,344 twin pregnancies
por: Wojas, Anna, et al.
Publicado: (2022)

Characteristics of Donor-Specific Antibodies Associated With Antibody-Mediated Rejection in Lung Transplantation
por: Roux, Antoine, et al.
Publicado: (2017)

T-cell allorecognition of donor glutathione S-transferase T1 in plasma cell-rich rejection
por: Martínez-Bravo, María José, et al.
Publicado: (2017)

How Do We Interpret the Presence of Donor-Specific Antibodies When There Is No Rejection?
por: Crew, R. John, et al.
Publicado: (2019)

Donor-Specific Antibodies in the Absence of Rejection Are Not a Risk Factor for Allograft Failure
por: Parajuli, Sandesh, et al.
Publicado: (2019)

Obstacles to the deceased donor transplantation in Pakistan
por: Ullah, Kaleem, et al.
Publicado: (2023)

Effect of Optimized Immunosuppression (Including Rituximab) on Anti-Donor Alloresponses in Patients With Chronically Rejecting Renal Allografts
por: Shiu, Kin Yee, et al.
Publicado: (2020)

Virtual Outpatient Heart Failure Care - Lessons From the Covid-19 Era
por: Ugolini, Sharon, et al.
Publicado: (2020)

A Review of Biomarkers of Cardiac Allograft Rejection: Toward an Integrated Diagnosis of Rejection
por: Coutance, Guillaume, et al.
Publicado: (2022)

Biomaterials-enabled cornea regeneration in patients at high risk for rejection of donor tissue transplantation
por: Islam, M. Mirazul, et al.
Publicado: (2018)

Circulating Donor Heart Exosome Profiling Enables Noninvasive Detection of Antibody-mediated Rejection
por: Hu, Robert W., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_agd7ebvu6cfvtrcgmh74ssf70k